Atlas Trials

Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis

Clinical trial NCT01737879 · TERMINATED

Trial details

NCT number
NCT01737879
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Anemia
Start date
2012-10-01
Primary completion
2013-03-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.